Generalized Anxiety Disorder vs. Panic Disorder

Anxiety is an intrinsic facet of the human evolutionary survival apparatus, serving as an adaptive alarm system designed to mobilize physiological and cognitive resources in the face of perceived threat. However, when this defensive architecture becomes dysregulated, it manifests as debilitating clinical psychopathology. Within modern psychiatric nosology, Generalized Anxiety Disorder (GAD) and Panic Disorder (PD) represent two of the most prevalent and functionally impairing expressions of pathological anxiety. While both conditions share a core diathesis of negative affectivity and autonomic dysregulation, they diverge fundamentally in their phenomenological architecture, temporal dynamics, neurobiological substrates, and behavioral manifestations.

The clinical differentiation between Generalized Anxiety Disorder and Panic Disorder poses a persistent challenge for clinicians in primary care, emergency medicine, and psychiatric settings. In everyday clinical discourse, the term “anxiety” is frequently applied as a monolithic descriptor, obscuring the critical distinction between the continuous, future-oriented cognitive apprehension characteristic of GAD and the paroxysmal, catastrophic, interoceptive storm defining Panic Disorder. Conflating these two distinct pathological trajectories can lead to diagnostic errors, suboptimal therapeutic selection, inappropriate pharmacotherapeutic regimens, and prolonged patient distress.

To navigate this diagnostic intersection, clinicians must comprehend the underlying theoretical models, neurocircuitry, cognitive styles, and somatic manifestations that distinguish tonic, sustained apprehension from phasic, explosive terror. This article provides a comprehensive, evidence-based comparative analysis of Generalized Anxiety Disorder and Panic Disorder, elucidating their historical divergence, diagnostic thresholds, pathophysiological divergence, overlapping clinical characteristics, and specialized therapeutic paradigms.

1. Introduction: Differentiating Chronic Apprehension from Acute Panic

1.1 Defining Generalized Anxiety Disorder and Panic Disorder

Generalized Anxiety Disorder is characterized by pervasive, excessive, and uncontrollable worry across multiple life domains, persisting for at least six months. The cognitive signature of GAD is characterized by continuous cognitive vigilance and worst-case scenario forecasting regarding distal events, including occupational performance, personal health, familial safety, and financial solvency. Rather than mobilizing adaptive problem-solving behavior, this apprehension remains “free-floating,” shifting from one topic to another without resolution. Patients experiencing GAD endure a state of tonic arousal, in which the nervous system remains suspended in an unbroken posture of threat readiness. This chronic tension depletes cognitive reserves and produces sustained muscular and somatic distress.

Conversely, Panic Disorder is defined by recurrent, unexpected panic attacks—abrupt surges of intense fear or discomfort that accelerate to an acute peak within minutes. During these episodes, patients experience a catastrophic autonomic storm accompanied by symptoms such as tachyarrhythmia, diaphoresis, dyspnea, trembling, dizziness, and intense terror. Crucially, Panic Disorder requires not only the presence of paroxysmal attacks, but also the enduring, persistent fear of subsequent episodes or their functional consequences (such as suffering a myocardial infarction, losing cognitive control, or succumbing to sudden death). This anticipatory terror often precipitates significant maladaptive alterations in daily routines to evade potential somatic triggers.

Diagnostic ambiguity frequently arises because both conditions feature anticipatory apprehension and somatic hyperarousal. A clinician encountering a patient who reports constant physical tension, interrupted sleep, and bouts of elevated heart rate may struggle to determine whether these manifestations reflect the chronic somatic background of GAD or the anticipatory dread and panic attacks seen in Panic Disorder. Disentangling the continuous, low-to-moderate burn of generalized apprehension from the episodic, explosive nature of panic is the central clinical challenge in affective nosology.

1.2 Clinical Rationale for Comparative Analysis

Precision in differentiating between GAD and Panic Disorder is essential for guiding clinical interventions. In primary care and emergency departments, patients presenting with Panic Disorder are often subjected to repeated, expensive, and unnecessary medical workups—ranging from serial cardiac enzymes and 12-lead electrocardiograms to computed tomography scans—under the presumption of acute organic pathology such as myocardial infarction or pulmonary embolism. Recognizing panic attack phenomenology prevents medicalization of psychiatric symptoms, mitigates patient health anxiety, and conserves healthcare resources. Conversely, the insidious onset and somatic vagueness of GAD frequently lead to its underdiagnosis or its dismissal as ordinary life stress, leaving patients to suffer years of chronic functional impairment without targeted psychiatric care.

Moreover, while both disorders respond favorably to first-line psychopharmacological interventions such as Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), the trajectory of medication titration and response varies considerably. Patients with Panic Disorder typically display severe somatic hypersensitivity and may experience acute, iatrogenic worsening of panic sensations during the initial phase of antidepressant initiation, requiring cautious, low-dose titration schedules. In contrast, treatment algorithms for GAD emphasize long-term tonic stabilization and may integrate distinct secondary agents, such as buspirone or pregabalin, which show minimal efficacy in preventing acute panic attacks.

Psychotherapeutic specialization presents an even stronger argument for comparative discernment. Cognitive Behavioral Therapy (CBT) protocols diverge substantially between the two conditions. Panic Disorder demands targeted interoceptive exposure to extinguish conditioned fear to internal somatic sensations, along with in vivo exposure to remediate agoraphobic avoidance. Conversely, GAD protocols focus on intolerance of uncertainty, cognitive restructuring of meta-worry, applied relaxation, and worry postponement experiments. Utilizing a standard GAD protocol for Panic Disorder fails to address the interoceptive conditioning driving acute attacks, while applying panic-focused interoceptive exposures to a patient with GAD leaves the complex, verbal worry architecture unchallenged. Finally, understanding the elevated rates of comorbidity between the two conditions is crucial for sequencing interventions when they co-occur.

1.3 Historical Perspectives and Diagnostic Evolution

The contemporary nosological division between Generalized Anxiety Disorder and Panic Disorder is the product of a prolonged historical evolution. In 1895, Sigmund Freud introduced the unifying construct of Angstneurose (Anxiety Neurosis), conceptualizing acute, paroxysmal anxiety attacks and continuous, free-floating anxiety under a shared etiology. Freud postulated that both expressions stemmed from undischarged somatic sexual excitation transformed into psychic tension. For decades, psychodynamic and early descriptive psychiatry treated acute panic and chronic apprehension as quantitative variations of the same underlying neurosis, viewing panic as simply a more severe crest of baseline anxiety.

This unitary model was challenged in the 1960s through the work of Donald F. Klein. In his pharmacological investigations, Klein discovered that the tricyclic antidepressant imipramine blocked recurrent panic attacks, but left patients’ baseline anticipatory anxiety largely intact. This double dissociation demonstrated that episodic panic and continuous worry could be pharmacologically uncoupled, suggesting that distinct biological and psychopathological mechanisms underlie the two phenomena. Klein’s pharmacological dissection demonstrated that panic attacks were not merely acute escalations of anticipatory worry, but qualitatively distinct neurobiological events.

Empowered by Klein’s findings, the American Psychiatric Association codified this nosological split in 1980 with the publication of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), officially abandoning the unitary “Anxiety Neurosis” in favor of two distinct diagnoses: Panic Disorder and Generalized Anxiety Disorder. Subsequent editions, from DSM-III-R to DSM-5-TR, and the World Health Organization’s International Classification of Diseases (ICD-10 and ICD-11), have refined these categorical criteria, tightening the duration thresholds for GAD and distinguishing panic attacks with or without agoraphobia. Concurrently, contemporary research initiatives, such as the National Institute of Mental Health’s Research Domain Criteria (RDoC) and the Hierarchical Taxonomy of Psychopathology (HiTOP), investigate both categorical distinctions and dimensional transdiagnostic features, examining whether these conditions represent distinct neurobiological modules or divergent expressions of a shared internalizing spectrum.

2. Understanding Generalized Anxiety Disorder (GAD)

2.1 Diagnostic Criteria and Symptom Dimensions

According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), the core diagnostic criterion for Generalized Anxiety Disorder is excessive anxiety and worry (apprehensive expectation), occurring more days than not for a minimum of six months, across a range of events, activities, or domains. The individual must find it distinctly difficult to control the worry. Unlike normal stress, which is typically proportional to external circumstances and responsive to reassurance or situational resolution, GAD-associated worry is excessive, shifts continually among diverse themes, and proves resistant to deliberate cognitive control.

In addition to the cognitive component of uncontrollable worry, the DSM-5-TR mandates that the anxiety be accompanied by at least three of the following six somatic and cognitive symptoms in adults (with only one symptom required for children):

• Restlessness or feeling keyed up or on edge: A continuous sense of neuromuscular readiness and psychic agitation.
• Easy fatigability: Profound, non-restorative depletion of energy stores stemming from constant, low-level muscle activation and cognitive labor.
• Difficulty concentrating or mind going blank: Executive function interruptions caused by intrusive, task-irrelevant threat cognitions monopolizing working memory capacity.
• Irritability: Affective volatility and low frustration tolerance generated by the strain of persistent distress.
• Muscle tension: Striated neuromuscular contraction, often manifesting as chronic myofascial pain, stiffness in the neck and shoulders, or tension-type headaches.
• Sleep disturbance: Difficulty initiating or maintaining sleep, or restless, unrefreshing sleep resulting from continuous cognitive hyperarousal and inability to quiet internal self-talk.

To meet diagnostic thresholds, the symptom complex must cause clinically significant distress or functional impairment across occupational, social, academic, or other essential domains of life, and must not be attributable to the direct physiological effects of a substance, medication, or general medical condition, nor better explained by another psychiatric illness.

2.2 Cognitive and Behavioral Profiles

The cognitive hallmark of GAD is “free-floating” worry, characterized by a persistent and pervasive intolerance of uncertainty. Individuals with GAD perceive ambiguous or unpredictable situations as inherently threatening. They treat low-probability catastrophic outcomes as imminent emergencies, employing worry as an attempt to mentally prepare for and neutralize every conceivable adverse scenario. This phenomenon was synthesized by Thomas Borkovec in his Cognitive Avoidance Theory of Worry. Borkovec posited that worry is an internal, verbally mediated process that inhibits vivid mental imagery and its associated autonomic activation. By dwelling in abstract, linguistic-verbal catastrophic ideation, the individual blunts intense somatic emotional processing, paradoxical as it may seem. Because the anticipated catastrophes rarely occur, the act of worrying is negatively reinforced through superstitious conditioning, reinforcing the belief that “worrying prevented the disaster.”

Adrian Wells expanded this cognitive framework through the Metacognitive Model of GAD, distinguishing between Type 1 and Type 2 worry. Type 1 worry involves appraisal of external threat events and everyday non-cognitive situations (e.g., “What if my spouse gets into an automobile accident?”). In contrast, Type 2 worry—termed “meta-worry”—involves catastrophic appraisals of the worry process itself (e.g., “My worrying is out of control and will drive me insane,” or “This stress will give me a fatal stroke”). When meta-worry activates, it triggers severe affective distress, cognitive fragmentation, and maladaptive efforts to suppress thought patterns, which systematically heightens threat vigilance and cognitive intrusion.

Behaviorally, GAD is maintained by subtle avoidance strategies and perpetual reassurance-seeking behaviors. Patients may make dozens of phone calls to verify a family member’s safety, obsessively check bank statements, over-prepare for minor presentations, or delegate decision-making to avoid responsibility for uncertain outcomes. Conversely, some exhibit behavioral procrastination, delaying tasks whose outcomes cannot be guaranteed. These safety and avoidance behaviors prevent the patient from testing their catastrophic predictions against reality, entrenching the cognitive vulnerability.

2.3 Neurobiological Mechanisms of Sustained Worry

The neurobiology of Generalized Anxiety Disorder is characterized by functional and structural aberrations within frontolimbic networks responsible for emotional evaluation and cognitive control. Neuroimaging investigations consistently identify functional hypoactivity within regulatory prefrontal regions, notably the ventromedial prefrontal cortex (vmPFC) and the dorsolateral prefrontal cortex (dlPFC). Under normative conditions, these prefrontal regions exert inhibitory top-down control over subcortical limbic structures. In GAD, this top-down braking mechanism fails, permitting sustained, uncalibrated activation of the basolateral amygdala. Furthermore, connectivity analyses reveal dysregulated cross-talk between the default mode network (DMN), which governs self-referential mental activity, and the salience network, leading to excessive internal preoccupation with threat cues.

At the neurochemical and subcortical level, GAD involves the extended amygdala, particularly the bed nucleus of the stria terminalis (BNST). While the central nucleus of the amygdala orchestrates phasic responses to immediate, discrete cues, the BNST is the primary mediator of sustained, tonic apprehension elicited by temporally unpredictable, ambiguous threats—the defining feature of generalized worry. This prolonged limbic activation cascades into chronic dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. Rather than exhibiting acute spikes followed by rapid negative-feedback normalization, individuals with GAD often demonstrate flattened diurnal cortisol slopes, sustained daytime hypercortisolemia, or atypical baseline cortisol secretion, contributing to systemic low-grade inflammation and neuromuscular fatigue.

Neurotransmitter dynamics in GAD are marked by alterations across GABAergic, serotonergic, and noradrenergic systems. Deficiencies in gamma-aminobutyric acid (GABA) neurotransmission, particularly involving structural variations in the GABA-A receptor complex, diminish the central nervous system’s capacity to induce global neuronal inhibition. Concurrently, altered 5-HT1A somatodendritic autoreceptor sensitivity within the dorsal raphe nucleus blunts normal serotonergic modulation of mood and fear circuits, while tonic elevation of noradrenergic tone within the locus coeruleus perpetuates hypervigilance, keeping somatic motor centers persistently activated.

3. Understanding Panic Disorder

3.1 Diagnostic Criteria and Panic Attack Phenomenology

Panic Disorder is diagnosed under DSM-5-TR criteria when an individual experiences recurrent, unexpected panic attacks, accompanied by at least one month of persistent concern about additional attacks, worry over their implications, or substantial maladaptive changes in behavior directly related to the attacks. The defining feature of a panic attack is an abrupt surge of intense fear or intense discomfort that reaches its peak within minutes. During this surge, four or more of the following thirteen somatic and cognitive symptoms must be present:

• Palpitations, pounding heart, or accelerated heart rate.
• Sweating (diaphoresis).
• Trembling or shaking.
• Sensations of shortness of breath or smothering (dyspnea).
• Feelings of choking.
• Chest pain or discomfort.
• Nausea or abdominal distress.
• Feeling dizzy, unsteady, light-headed, or faint.
• Chills or heat sensations.
• Paresthesias (numbness or tingling sensations, particularly perioral or in extremities).
• Derealization (feelings of unreality) or depersonalization (being detached from oneself).
• Fear of losing control or “going crazy.”
• Fear of dying.

The phenomenological hallmark of a classic panic attack is its explosive trajectory. The transition from baseline composure to peak autonomic activation typically transpires within seconds to minutes, overwhelming the patient’s cognitive and behavioral coping mechanisms. The catastrophic cognitions are immediate, visceral, and acute: the sensation of an accelerated heart rate is instantly appraised as an evolving fatal myocardial infarction; tachypnea and hyperventilation are misconstrued as asphyxiation; dizziness and depersonalization are interpreted as imminent loss of sanity, stroke, or complete neurological collapse.

3.2 Anticipatory Anxiety and Behavioral Adaptation

While the acute panic paroxysm is the defining event of the condition, Panic Disorder as a chronic illness is maintained by the behavioral and cognitive aftermath of these attacks. Once an unexpected panic attack has occurred, the patient develops profound anticipatory anxiety—a persistent, dread-infused vigilance directed inward toward their own internal somatic sensations. The individual enters a state of heightened interoceptive monitoring, scanning their body for minor physiological fluctuations. An innocuous elevation in heart rate from climbing stairs, transient lightheadedness from standing up quickly, or mild dyspnea induced by a stuffy room is immediately perceived as a harbinger of another attack.

This interoceptive conditioning is conceptualized by David M. Clark’s Cognitive Model of Panic. According to Clark, panic attacks are maintained by a vicious cycle: an internal or external trigger produces a subtle physiological change; this sensation is subjected to immediate catastrophic misinterpretation; the catastrophic thought provokes an abrupt surge of autonomic arousal via sympathetic discharge; the surge amplifies the physiological sensations; and the intensified sensations validate the catastrophic cognition, spiraling into a full-blown panic attack.

To cope with this cycle, individuals systematically develop behavioral adaptations, notably agoraphobia and extensive safety behaviors. Agoraphobia—now codified in DSM-5 as an independent diagnosis, yet historically and clinically linked with Panic Disorder—involves marked fear or avoidance of situations where escape might be difficult or help unavailable should panic-like symptoms emerge. Patients begin avoiding crowded marketplaces, public transportation, enclosed venues, bridges, and open spaces, eventually becoming housebound in severe cases. Even when venturing outside their safe zones, they often deploy subtle safety behaviors: carrying emergency benzodiazepine tablets, clutching bottles of water, sitting exclusively near exits, or requiring a trusted companion. These behaviors preserve the patient’s core belief that avoidance or safety rituals saved them from catastrophic collapse, preventing natural extinction of the panic response.

3.3 Neurobiology of the Paroxysmal Panic Response

The neurobiological architecture of Panic Disorder diverges significantly from the extended apprehension circuitry of GAD. Panic represents an acute activation of the brainstem-centered “fear network” and primal suffocation alarm systems. Contemporary neuroanatomical models, pioneered by Jack Gorman and colleagues, delineate an over-reactive fear network encompassing the central nucleus of the amygdala, the hippocampus, the periaqueductal gray (PAG), the parabrachial nucleus, and the locus coeruleus.

During an acute panic attack, this network fires explosively via a rapid subcortical pathway—often termed the thalamo-amygdalar “low road.” Sensory or interoceptive inputs bypass the slower, evaluative neocortex, projecting straight from the thalamus to the amygdala. The central nucleus of the amygdala immediately triggers effector sites across the brainstem and hypothalamus: the lateral hypothalamus fires to stimulate the sympathetic nervous system (producing tachycardia, hypertension, and mydriasis); the paraventricular nucleus triggers corticotropin-releasing hormone release; the locus coeruleus discharges massive bursts of norepinephrine, driving acute terror and peripheral vasoconstriction; and the periaqueductal gray initiates freeze-fight-or-flight motor behaviors.

A crucial component of panic neurobiology is Donald Klein’s Suffocation False Alarm Theory, later refined by neurochemical research into central chemoreceptors. The brainstem, particularly within the dorsal raphe, nucleus tractus solitarii, and locus coeruleus, possesses specialized chemosensitive neurons that monitor arterial carbon dioxide ($CO_2$), lactate, and proton concentrations. In patients with Panic Disorder, this physiological monitoring system operates under an abnormally low threshold. Minor, transient elevations in endogenous $CO_2$ or serum lactate are misinterpreted by the brainstem as life-threatening asphyxiation. This triggers an involuntary suffocation alarm, producing the dyspnea, hyperventilation, air hunger, and extreme panic seen in the disorder. This chemoreceptor hypersensitivity is demonstrated in laboratory settings, where intravenous infusions of sodium lactate or inhalations of 35% $CO_2$ air reliably precipitate panic attacks in Panic Disorder patients, while rarely doing so in healthy individuals or those with GAD.

4. Key Differences: Generalized Anxiety Disorder vs. Panic Disorder

4.1 Temporal Dynamics and Symptom Onset

The distinction between Generalized Anxiety Disorder and Panic Disorder rests primarily on their contrasting temporal architectures. Generalized Anxiety Disorder is an insidious, tonic, and continuous condition. Its onset is typically gradual, unfolding across months or years, with patients frequently reporting that they have “always been a worrier” since childhood or early adolescence. The temporal trajectory of GAD is characterized by uninterrupted chronicity. The symptom burden does not arrive in discrete, transient spikes; instead, it forms an elevated, ongoing baseline. While GAD symptoms fluctuate in intensity according to external environmental demands, they endure across weeks and months, with symptom peaks persisting for days, weeks, or indefinitely without a clear resolution to a calm physiological baseline.

In sharp contrast, Panic Disorder is an episodic, phasic, and paroxysmal disorder. Its hallmark is the acute panic attack, which erupts with sudden velocity from a non-anxious state or a baseline of mild anticipatory apprehension. The temporal course of an individual attack follows a steep curve: autonomic symptoms surge rapidly, peaking within 10 minutes, and typically resolving within 20 to 30 minutes as physiological homeostatic mechanisms, such as parasympathetic rebound and baroreceptor reflexes, act to prevent metabolic exhaustion. While the anticipatory anxiety surrounding future attacks can become continuous, the primary pathology of Panic Disorder consists of discrete, recurring, time-limited crises, contrasted against the unbroken hum of GAD.

4.2 Cognitive Focus: Diffuse Anticipation vs. Imminent Catastrophe

The cognitive architectures of GAD and Panic Disorder target distinct temporal horizons, threat loci, and semantic content. In GAD, the cognitive focus is distal, macro-situational, and future-oriented. The individual’s thoughts dwell on events that may occur in days, months, or years. The content of generalized worry centers primarily on psychosocial, economic, and interpersonal realities:

• “What if my child fails out of school and ruins their life?”
• “What if the economy crashes and we cannot pay the mortgage next year?”
• “What if this minor mistake at work leads to my eventual termination?”

The threat is external, hypothetical, and distributed across multiple life domains. While the person acknowledges that these outcomes have not occurred yet, they engage in exhaustive cognitive preparation to mitigate them. Intolerance of uncertainty drives this rumination; the patient cannot accept the ambiguity inherent in future outcomes.

In Panic Disorder, the cognitive focus is immediate, micro-somatic, and localized within the present moment. The locus of threat is internal. Rather than scanning the external psychosocial environment for potential crises, the panic patient’s cognitive system monitors their internal milieu. The cognitive distortions in Panic Disorder are acute, catastrophic misinterpretations of normal or minor physiological sensations:

• “My heart skipped a beat; I am suffering a massive heart attack right now.”
• “I feel lightheaded; I am about to faint, lose consciousness, or have a seizure.”
• “This unreality feeling means I am experiencing a psychotic break.”

There is no distal time horizon in a panic attack; the catastrophe is not an ambiguous possibility that might occur next month, but an imminent biological disaster occurring within the next few seconds.

4.3 Physiological and Somatic Differentiation

Although both disorders involve autonomic dysregulation, their somatic profiles reflect different neurovegetative states. Generalized Anxiety Disorder is characterized by chronic, sustained neuromuscular tension and low-to-moderate sympathetic tone. The body is positioned in continuous vigilance, leading to striated muscle contraction across the trapezius, cervical, and lumbar regions. Patients complain of muscular soreness, stiff joints, tension headaches, and persistent jaw clenching (bruxism). The gastrointestinal profile of GAD leans toward functional bowel alterations, such as Irritable Bowel Syndrome (IBS), chronic epigastric discomfort, and stress-related dyspepsia, driven by sustained corticotropin-releasing factor secretion altering gut motility and mucosal permeability. Autonomic arousal in GAD does not reach high extremes; resting heart rate may be mildly elevated and heart rate variability (HRV) is chronically suppressed, reflecting diminished parasympathetic vagal tone, yet acute autonomic decompensation is absent.

In contrast, Panic Disorder produces an intense sympathetic storm that temporarily overwhelms bodily homeostasis. During an attack, the sympathetic-adrenal-medullary axis discharges catecholamines, causing rapid physiological shifts. Cardiorespiratory symptoms dominate the clinical picture: profound tachycardia, supraventricular runs, sudden hypertensive surges, air hunger, and tachypnea. The rapid hyperventilation flushes carbon dioxide from the pulmonary alveoli, inducing acute hypocapnia and respiratory alkalosis. This systemic alkalosis reduces ionized serum calcium, triggering peripheral vasoconstriction, paresthesias (tingling in fingers, toes, and perioral areas), lightheadedness, carpopedal spasms, and intense vestibular disorientation. Panic patients experience visceral sensations of choking and suffocation. While a GAD patient endures somatic exhaustion and chronic tension, a panic patient encounters acute autonomic crises that mimic emergency medical conditions.

4.4 Comparative Clinical Parameter Matrix

To assist clinicians in systematically evaluating and distinguishing these two complex diagnostic entities, the following matrix outlines their clinical, physiological, cognitive, and therapeutic parameters:

Clinical Parameter	Generalized Anxiety Disorder (GAD)	Panic Disorder (PD)
Core Defining Feature	Pervasive, uncontrollable, excessive worry regarding multiple everyday domains.	Recurrent, unexpected panic attacks and fear of subsequent attacks or their consequences.
Diagnostic Minimum Duration	At least 6 months, occurring more days than not.	At least 1 month of persistent worry/behavioral adaptation following an attack.
Temporal Dynamics	Insidious onset, tonic, continuous, chronic course with low-frequency fluctuations.	Abrupt onset, phasic, paroxysmal attacks peaking within 10 minutes; episodic course.
Cognitive Threat Locus	Distal, external, future-oriented events (finances, health, career, loved ones).	Proximal, internal, immediate physiological sensations (catastrophic somatic misinterpretation).
Primary Somatic Presentation	Striated muscle tension, fatigue, restlessness, tension headaches, chronic gastrointestinal distress.	Cardiorespiratory and vestibular surges: tachycardia, dyspnea, chest pain, vertigo, paresthesias.
Neurobiological Focus	Hypoactive vmPFC/dlPFC; sustained bed nucleus of the stria terminalis (BNST) hyperactivation; HPA axis dysregulation.	Hyperactive brainstem fear network (locus coeruleus, periaqueductal gray); hypersensitive $CO_2$ chemoreceptors; subcortical amygdala firing.
Standard Psychometrics	GAD-7, Penn State Worry Questionnaire (PSWQ).	Panic Disorder Severity Scale (PDSS), Anxiety Sensitivity Index (ASI-3).
Behavioral Modifications	Reassurance seeking, chronic over-preparation, behavioral procrastination, intolerance of uncertainty.	Agoraphobic avoidance of physical spaces, interoceptive avoidance (avoiding exercise, caffeine), carrying safety objects.
Primary CBT Strategy	Worry postponement, cognitive restructuring of meta-worry, applied relaxation, uncertainty exposure.	Interoceptive exposure (somatic provocation), in vivo situational exposure, cognitive restructuring of physical catastrophes.
Healthcare Utilization	Frequent visits to primary care, rheumatology, and gastroenterology for vague somatic complaints.	High emergency department and cardiology utilization due to feared acute cardiac, pulmonary, or neurological collapse.

The behavioral adaptations and patterns of healthcare utilization between these conditions illustrate their practical divergence. Patients with Panic Disorder generate substantial medical costs in acute care settings. Convinced that their somatic symptoms indicate an acute medical emergency, they repeatedly present to emergency departments, often arriving by ambulance. They demand continuous cardiac telemetry, coronary angiography, and neurological workups. In contrast, patients with Generalized Anxiety Disorder use outpatient healthcare frequently across many years. They present to primary care physicians, gastroenterologists, and rheumatologists with vague, persistent complaints: functional dyspepsia, chronic neck pain, unremitting fatigue, or fibromyalgia-like symptoms. Their functional impairment is distributed broadly, eroding daily performance and social participation through ongoing cognitive fatigue.

5. Similarities and Clinical Overlap

5.1 Shared Genetic and Neurobiological Vulnerabilities

Despite their distinct clinical presentations, Generalized Anxiety Disorder and Panic Disorder share a substantial underlying neurobiological diathesis. Quantitative behavioral genetics studies, including large-scale twin registries, indicate that both disorders exhibit moderate heritability, with genetic factors accounting for approximately 30% to 40% of the phenotypic variance. Crucially, multivariate genetic modeling reveals that this heritable component is largely non-specific. Rather than inheriting independent genes for GAD or Panic Disorder, individuals inherit a common polygenic risk architecture linked to the broad higher-order personality dimension of neuroticism, or negative affectivity.

Neuroticism represents a biological tendency to perceive the world as threatening, to experience negative emotional states (such as anxiety, guilt, and anger) with heightened frequency and intensity, and to cope poorly with acute stressors. This underlying vulnerability is reflected in shared alterations across frontolimbic emotional processing networks. Both GAD and Panic Disorder patients demonstrate functional and structural connectivity deficits between the prefrontal cortex and the amygdala, resulting in impaired fear extinction learning and dysregulated emotional salience processing. Furthermore, both patient populations display altered autonomic nervous system flexibility, characterized by reductions in baseline respiratory sinus arrhythmia and low Heart Rate Variability (HRV). This shared autonomic inflexibility indicates an impaired capacity of the parasympathetic nervous system to flexibly downregulate arousal in response to changing environmental demands.

5.2 Comorbidity and Diagnostic Blurring

In clinical practice, categorical boundaries frequently blur, and comorbidity between Generalized Anxiety Disorder and Panic Disorder is common. Epidemiological investigations, such as the National Comorbidity Survey, demonstrate that between 25% and 50% of individuals diagnosed with Panic Disorder also meet the full diagnostic criteria for GAD, and vice versa. This diagnostic intersection frequently follows a reciprocal, mutually reinforcing developmental trajectory.

A patient with long-standing Generalized Anxiety Disorder may experience an elevation in baseline physiological arousal due to ongoing stress or sleep loss. This chronic somatic tension lowers the biological threshold required to trigger an acute panic paroxysm. When an unexpected panic attack finally erupts, the individual’s established habit of threat-monitoring incorporates these acute bodily sensations into their worry repertoire, accelerating the onset of full Panic Disorder. Conversely, an individual who initially develops Panic Disorder may discover that the constant, dread-filled vigilance directed toward their internal state gradually broadens. Over months, this anticipatory dread expands beyond the panic attacks themselves, evolving into generalized, macro-domain worry regarding employment stability, marital security, medical bills, and personal safety, fulfilling the criteria for GAD.

Furthermore, both disorders are potent risk factors for the emergence of secondary and tertiary psychiatric conditions. The chronicity and functional impairment associated with both illnesses often lead to the development of comorbid Major Depressive Disorder (MDD), producing an internalizing triad (GAD, Panic Disorder, and Depression) characterized by greater symptom severity, higher functional disability, elevated suicide risk, and diminished responsiveness to standard interventions. Additionally, patients with either condition frequently turn to self-medication strategies, substantially increasing the risk of secondary alcohol or substance use disorders—particularly central nervous system depressants, such as alcohol and diverted benzodiazepines, used to blunt autonomic hyperarousal.

5.3 Overlapping Pharmacotherapeutic and Psychotherapeutic Interventions

Because GAD and Panic Disorder share underlying neurochemical and psychological vulnerabilities, their evidence-based treatment algorithms exhibit significant therapeutic overlap. In psychopharmacology, Selective Serotonin Reuptake Inhibitors (SSRIs)—such as escitalopram, sertraline, and paroxetine—and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)—such as venlafaxine and duloxetine—represent the empirical first-line pharmacotherapies for both conditions. These agents normalize frontolimbic connectivity, desensitize hypersensitive serotonin autoreceptors in the dorsal raphe, and downregulate hyperactive amygdalar signaling over extended administration.

Similarly, Cognitive Behavioral Therapy (CBT) represents the gold-standard psychosocial intervention for both conditions, operating through shared theoretical principles. Psychoeducation regarding the evolutionary utility of the autonomic nervous system and the physiological mechanisms of fear serves as the initial step in both GAD and panic protocols. In both conditions, cognitive restructuring is utilized to identify, evaluate, and challenge systematic cognitive distortions, such as catastrophizing, probability overestimation, and dichotomous thinking. Patients in both treatment paradigms learn to decouple objective threat from subjective fear, recognizing that intense emotional discomfort does not necessarily signal real danger.

Beyond formal psychotherapy and psychopharmacology, transdiagnostic lifestyle and complementary strategies show utility across both conditions. Interventions targeting sleep architecture restoration, systematic physical exercise, the reduction of stimulants (particularly caffeine and sympathomimetic agents), and mindfulness-based stress reduction (MBSR) provide meaningful reductions in autonomic hyperarousal. Exercise, in particular, exerts dual therapeutic utility: in GAD, it exhausts chronic striated muscle tension and promotes neuroplasticity via brain-derived neurotrophic factor (BDNF) synthesis; in Panic Disorder, aerobic exercise functions as a mild, natural form of interoceptive exposure, habituating the patient to elevated heart rates and respiration within a safe context.

6. Clinical Assessment and Differential Diagnostic Application

6.1 Structured Clinical Assessment and Psychometrics

An accurate differential diagnosis between Generalized Anxiety Disorder and Panic Disorder requires a structured clinical assessment strategy combining validated psychometric scales with targeted clinical interviewing. For Generalized Anxiety Disorder, the 7-item Generalized Anxiety Disorder scale (GAD-7) serves as a rapid, reliable screening instrument with established psychometric properties. For a deeper assessment of cognitive worry dimensions, clinicians utilize the Penn State Worry Questionnaire (PSWQ), a 16-item inventory that measures the generality, excessiveness, and uncontrollability of pathological worry, effectively distinguishing GAD from other affective conditions.

To evaluate Panic Disorder, clinicians rely on the Panic Disorder Severity Scale (PDSS), an established instrument measuring attack frequency, distress during attacks, anticipatory anxiety, agoraphobic avoidance, and functional impairment. In tandem, the Anxiety Sensitivity Index (ASI-3) provides insight into the cognitive vulnerability underlying panic by evaluating “anxiety sensitivity”—the fear of anxiety-related bodily sensations based on beliefs about their harmful somatic, psychological, or social consequences. Elevated ASI-3 scores, particularly on the physical concerns subscale, strongly suggest panic pathology rather than pure generalized apprehension.

Crucially, before finalizing a psychiatric diagnosis, clinicians must conduct a thorough medical evaluation to rule out organic etiologies that mimic panic and generalized anxiety. The differential medical workup should include:

• Endocrine screening: Thyroid-stimulating hormone (TSH) and free thyroxine ($FT_4$) to rule out hyperthyroidism, which causes continuous restlessness, fine tremors, heat intolerance, and episodic palpitations.
• Cardiovascular assessment: Resting 12-lead electrocardiogram (ECG) and, when clinically indicated, 24-to-48-hour Holter monitoring to differentiate panic attacks from paroxysmal supraventricular tachycardias (SVT), Wolff-Parkinson-White syndrome, atrial fibrillation, or symptomatic mitral valve prolapse.
• Neuroendocrine evaluation: Plasma free metanephrines or 24-hour urinary fractionated metanephrines to rule out pheochromocytoma, a rare catecholamine-secreting neuroendocrine tumor that triggers paroxysmal sympathetic storms characterized by hypertension, headache, diaphoresis, and palpitations.
• Metabolic panels: Fasting blood glucose to assess for episodic hypoglycemia, along with complete metabolic profiles to exclude significant electrolyte disturbances.
• Toxicology and substance review: Comprehensive evaluation of caffeine consumption, nicotine use, stimulant medications (e.g., prescribed amphetamines or methylphenidate), over-the-counter decongestants containing pseudoephedrine, and withdrawal states from central nervous system depressants (such as alcohol, benzodiazepines, or barbiturates), which can provoke severe autonomic surges.

A specialized diagnostic challenge involves distinguishing nocturnal panic attacks from other sleep-related disturbances. Nocturnal panic attacks occur in a substantial subset of patients with Panic Disorder. These episodes are characterized by waking abruptly from sleep in a state of severe autonomic terror, marked by diaphoresis, tachycardia, and dyspnea. Crucially, nocturnal panic attacks occur during the transition from non-REM stage 2 to stage 3 delta sleep, rather than during REM sleep, meaning they are not triggered by vivid nightmares. This presentation must be differentiated from sleep terrors (which are characterized by retrograde amnesia for the event and prolonged post-arousal disorientation), obstructive sleep apnea (OSA, which features gasping, stertorous breathing, and daytime somnolence, identifiable via polysomnography), and the sleep-onset insomnia seen in GAD, where the individual remains awake for hours caught in verbal worry loops.

6.2 Therapeutic Allocation Based on Primary Pathology

While basic psychoeducation and SSRI pharmacotherapy represent shared therapeutic tools, clinical outcomes improve when psychological interventions are tailored to the primary underlying pathology. Clinicians must determine whether the patient’s primary distress is driven by interoceptive panic conditioning or verbal-cognitive worry, directing treatment toward the appropriate targeted protocol.

When Panic Disorder is identified as the primary condition, treatment should center on Panic Control Therapy (PCT), pioneered by David H. Barlow and Michelle Craske. The essential component of this protocol is systematic interoceptive exposure. The goal is to deliberately reproduce the patient’s feared bodily sensations in a controlled clinical environment to dismantle the conditioned catastrophic misinterpretation of internal cues. The therapist guides the patient through specific, standardized exercises designed to simulate panic sensations:

• Hyperventilation: Rapid, deep breathing for 60 to 90 seconds to induce hypocapnia, dizziness, lightheadedness, and derealization.
• Straw breathing: Inhaling through a narrow drinking straw while pinching the nostrils shut for 1 to 2 minutes to induce acute airway resistance, chest tightness, and air hunger.
• Chair spinning: Rotating the patient in a swivel chair for 60 seconds to elicit acute vestibular disorientation and vertigo.
• Head dropping / sudden standing: Dropping the head between the knees for 30 seconds and rapidly sitting upright to induce postural blood pressure shifts, lightheadedness, and visual field changes.
• Running in place: Intensive stationary running to rapidly elevate heart rate and induce heavy respiration.

Through repeated, prolonged interoceptive exposure, the patient undergoes inhibitory learning: they experience the feared somatic sensations without escaping or relying on safety behaviors, directly disconfirming the catastrophic prediction that these sensations lead to death, insanity, or physical collapse. Once interoceptive habituation is achieved, the clinician pairs this with in vivo exposure hierarchies to systematically extinguish agoraphobic avoidance in external environments.

Conversely, applying interoceptive exposure to a patient whose primary pathology is Generalized Anxiety Disorder is ineffective, as their core pathology does not stem from fear of internal somatic sensations. For GAD, the therapeutic framework shifts toward targeting the verbal worry architecture and the underlying intolerance of uncertainty. Established evidence-based protocols include:

• Intolerance of Uncertainty Therapy (IUT): Developed by Michel Dugas and colleagues, this intervention targets the core cognitive vulnerability of GAD. Patients learn to identify their cognitive threshold for ambiguity, re-evaluate their beliefs regarding the utility of worry (e.g., challenging the idea that “worrying prevents misfortune”), and engage in behavioral experiments that involve actively embracing minor, controlled uncertainties in daily life without relying on reassurance or over-preparation.
• Metacognitive Therapy (MCT): Formulated by Adrian Wells, this model addresses the patient’s beliefs about their worry processes. Therapy focuses on restructuring Type 2 worry (meta-worry) through techniques such as detached mindfulness, worry postponement experiments (scheduling a 15-minute “worry window” later in the day), and challenging beliefs regarding the uncontrollability and physical danger of thoughts.
• Applied Relaxation: Developed by Lars-Göran Öst, this physiological protocol trains patients to recognize the earliest micro-signals of striated muscle tension and rapidly deploy conditioned relaxation techniques (progressive muscle relaxation transitioning into cue-controlled and rapid breathing relaxation) to counter the slow accumulation of neuromuscular stress throughout the day.

6.3 Decision-Making in Complex and Refractory Cases

In complex psychiatric presentations where Generalized Anxiety Disorder and Panic Disorder occur simultaneously with severe intensity, clinicians face the challenge of treatment sequencing. Determining which condition to target first requires evaluating functional impairment, acute safety risks, and therapeutic accessibility. As a general clinical guideline, when Panic Disorder is accompanied by significant agoraphobia, it should be treated as the primary initial therapeutic target. Severe agoraphobia and unpredictable panic attacks cause acute, immediate behavioral paralysis, often preventing the patient from consistently attending clinical appointments, maintaining employment, or engaging in the reflective cognitive work necessary for GAD therapy. Stabilizing panic and restoring baseline mobility through panic control therapy and pharmacotherapy provides the psychological stability required to subsequently address more diffuse, chronic worry architectures.

In treatment-resistant or refractory cases—defined by a failure to respond to adequate trials of two or more first-line SSRIs/SNRIs and a full course of evidence-based CBT—clinicians must deploy carefully considered augmentation and consolidation strategies:

• Pharmacological Augmentation: For refractory GAD, evidence supports augmenting antidepressant therapy with pregabalin, a voltage-gated calcium channel alpha-2-delta ligand that reduces the excessive release of excitatory neurotransmitters (such as glutamate and substance P), providing anxiolytic and muscle-relaxing effects without modulating GABA receptors directly. Alternatively, low-dose atypical antipsychotics with high 5-HT2A receptor antagonism (such as quetiapine or aripiprazole) can be considered, weighing their anxiolytic efficacy against potential metabolic risks. For refractory Panic Disorder, augmentation with high-potency benzodiazepines (such as clonazepam or alprazolam) may be utilized with caution as a short-term stabilizing bridge, though long-term dependence, tolerance, and interference with CBT-mediated exposure learning present real concerns. In select treatment-resistant panic cases, switching to or augmenting with a tricyclic antidepressant (TCA) such as imipramine or clomipramine remains a proven pharmacological alternative.
• Intensive and Virtual Reality Exposure Protocols: For patients with severe agoraphobic avoidance who are homebound or unable to travel to treatment, Virtual Reality Exposure Therapy (VRET) can serve as an accessible intermediate step, exposing the patient to simulated elevators, crowds, airplanes, and bridges before progressing to in vivo exposure. Intensive, multi-day exposure formats can also help disrupt deep avoidance patterns in refractory panic.
• Mindfulness and Acceptance Consolidation: When cognitive restructuring produces diminishing returns in chronic GAD, incorporating Acceptance and Commitment Therapy (ACT) can be beneficial. ACT helps shift the clinical focus away from trying to eliminate or control worry thoughts, guiding the patient instead to accept distressing internal states while refocusing cognitive energy toward meaningful, value-congruent behavioral actions.

7. Frequently Asked Questions

7.1 Can a Person Suffer from Both GAD and Panic Disorder Simultaneously?

Yes, an individual can be diagnosed with both Generalized Anxiety Disorder and Panic Disorder simultaneously. Psychiatric classification systems, including the DSM-5-TR and ICD-11, permit dual diagnoses whenever a patient independently fulfills the complete criteria for each condition. Comorbidity between these two disorders is common rather than exceptional; epidemiological studies demonstrate that approximately one-third of individuals with Panic Disorder also meet the criteria for GAD, and an estimated one-quarter of GAD patients experience comorbid Panic Disorder.

When both conditions are present, they frequently interact to worsen overall psychopathology. The sustained autonomic hyperarousal and elevated baseline stress associated with chronic GAD lower the threshold for acute panic attacks, while the recurring trauma of panic attacks broadens the scope of generalized anticipatory worry. In clinical practice, treating these comorbid cases requires an integrated treatment plan: clinicians often stabilize acute panic attacks and associated agoraphobia first through interoceptive and situational exposure, followed by cognitive interventions targeting the chronic worry and intolerance of uncertainty characteristic of GAD.

7.2 How Does an ‘Anxiety Attack’ Differ from a Panic Attack?

The term “anxiety attack” is a colloquial phrase widely used by the public and popular media; it is not a formal, recognized diagnostic construct in the DSM-5-TR or ICD-11. When patients describe experiencing an “anxiety attack,” they are typically referring to an acute elevation of generalized anxiety. These episodes feature building cognitive worry, motor restlessness, and moderate physical tension triggered by identifiable external stressors—such as interpersonal conflict, financial difficulties, or academic pressure. These states generally build slowly over hours or days, persist for extended periods, and remain tied to real-world concerns.

In contrast, a panic attack is a clearly defined psychiatric entity characterized by an abrupt, intense surge of autonomic fear that peaks rapidly—typically within minutes. Panic attacks frequently occur “out of the blue” without an obvious external situational trigger, even waking individuals from deep sleep (nocturnal panic). Furthermore, the physiological sensations during a panic attack are more acute and severe, marked by hyperventilation, cardiac palpitations, severe dizziness, paresthesias, and depersonalization, accompanied by immediate catastrophic fears of dying, losing control, or having a heart attack. While an anxiety attack is an escalation of ongoing tension tied to external life stressors, a panic attack is a rapid, explosive sympathetic activation driven by catastrophic misinterpretation of internal sensations.

7.3 Which Disorder Has a More Favorable Long-Term Prognosis?

Longitudinal outcome data suggest that Panic Disorder generally carries a more favorable response to targeted, evidence-based treatments than Generalized Anxiety Disorder, though its untreated trajectory can be disruptive. Panic Disorder typically exhibits an episodic course characterized by acute crises. When treated with gold-standard interventions—particularly specialized Cognitive Behavioral Therapy emphasizing interoceptive exposure (Panic Control Therapy), paired with or without first-line SSRIs/SNRIs—remission rates for Panic Disorder are high, often reaching 70% to 80% in clinical trial settings. Extinguishing the conditioned fear of bodily sensations directly targets the maintaining mechanism of the illness, leading to durable symptom resolution.

In contrast, Generalized Anxiety Disorder is characterized by a more chronic, trait-like trajectory. GAD often emerges early in life, progresses insidiously, and demonstrates a waxing-and-waning course that can persist for decades if left unmanaged. While patients with GAD experience meaningful functional improvement and symptom reduction through therapies like Intolerance of Uncertainty CBT, Metacognitive Therapy, and pharmacotherapy, complete, sustained remission is more challenging to achieve. GAD’s cognitive worry architecture is deeply woven into an individual’s personality structure, cognitive style, and baseline stress reactivity. Long-term management of GAD typically requires ongoing deployment of adaptive behavioral habits, cognitive restructuring, and stress-reduction strategies over the lifespan.

8. Conclusion

8.1 Synthesis of Core Diagnostic Distinctions

The clinical distinction between Generalized Anxiety Disorder and Panic Disorder rests upon fundamentally different temporal, cognitive, and neurobiological foundations. Generalized Anxiety Disorder is a tonic, continuous condition characterized by persistent, uncontrollable worry regarding distal, future-oriented life domains. Its cognitive signature is marked by an intolerance of uncertainty, metacognitive fears of worry itself, and abstract verbal rumination. Physiologically, GAD manifests as persistent striated muscle tension, autonomic inflexibility, chronic fatigue, and functional gastrointestinal disturbances, driven by sustained activation of frontolimbic circuits involving the bed nucleus of the stria terminalis (BNST) and dysregulation of the hypothalamic-pituitary-adrenal axis.

Conversely, Panic Disorder is an episodic, phasic condition characterized by recurrent, unexpected surges of autonomic terror that peak within minutes. Its cognitive profile involves the catastrophic misinterpretation of immediate internal somatic sensations—such as heart palpitations, dyspnea, and dizziness—which are perceived as life-threatening emergencies. Physiologically, Panic Disorder is defined by acute sympathetic discharge, hyperventilation-induced respiratory alkalosis, and vestibular disorientation, driven by hyper-reactivity of the brainstem fear network, the locus coeruleus, and hypersensitive central chemoreceptors. While GAD endures as a chronic hum of future apprehension, Panic Disorder strikes as an immediate, visceral crisis of physical survival.

8.2 Implications for Evidence-Based Clinical Practice

Accurate nosological differentiation between these two conditions is an essential clinical responsibility. Precision in diagnosis prevents the inappropriate medicalization of psychiatric illness, curbs unnecessary emergency department evaluations, and avoids the misallocation of healthcare resources. Diagnostic clarity directly guides targeted treatment selection. For the patient with Panic Disorder, therapeutic success relies on extinguishing conditioned fear to internal somatic sensations via interoceptive exposure and dismantling agoraphobic avoidance. For the patient with Generalized Anxiety Disorder, success requires challenging verbal worry loops, fostering tolerance for ambiguity, and releasing chronic somatic tension through applied relaxation and cognitive interventions.

As psychiatric research advances toward dimensional models—such as the Research Domain Criteria (RDoC) and the Hierarchical Taxonomy of Psychopathology (HiTOP)—clinicians must integrate categorical precision with an appreciation of shared neurobiological and affective vulnerabilities. Recognizing how chronic generalized anxiety can prime an individual for acute panic, and how recurring panic can widen into generalized apprehension, provides a more nuanced approach to complex presentations. By distinguishing the tonic apprehension of GAD from the phasic terror of Panic Disorder, clinicians can deliver targeted, evidence-based care that mitigates suffering and restores long-term functional recovery.

References

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787

Barlow, D. H. (2002). Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed.). Guilford Press.

Borkovec, T. D., Ray, S. D., & Stöber, J. (1998). Worry: A cognitive phenomenon intimately linked to affective, physiological, and interpersonal processes. Cognitive Therapy and Research, 22(6), 561–576. https://doi.org/10.1023/A:1018790003416

Clark, D. M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24(4), 461–470. https://doi.org/10.1016/0005-7967(86)90011-2

Craske, M. G., & Barlow, D. H. (2014). Mastery of your anxiety and panic: Therapist guide (4th ed.). Oxford University Press.

Dugas, M. J., Gagnon, F., Ladouceur, R., & Freeston, M. H. (1998). Generalized anxiety disorder: A preliminary test of a conceptual model. Behaviour Research and Therapy, 36(2), 215–226. https://doi.org/10.1016/S0005-7967(97)10017-0

Freud, S. (1895). On the grounds for detaching a particular syndrome from neurasthenia under the description ‘anxiety neurosis’. In J. Strachey (Ed. & Trans.), The standard edition of the complete psychological works of Sigmund Freud (Vol. 3, pp. 85–115). Hogarth Press.

Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000). Neuroanatomical hypothesis of panic disorder, revised. The American Journal of Psychiatry, 157(4), 493–505. https://doi.org/10.1176/appi.ajp.157.4.493

Klein, D. F. (1964). Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia, 5(6), 397–408. https://doi.org/10.1007/BF00413244

Klein, D. F. (1993). False suffocation alarms, spontaneous panics, and related conditions: An integrative hypothesis. Archives of General Psychiatry, 50(4), 306–317. https://doi.org/10.1001/archpsyc.1993.01820160076009

Wells, A. (1995). Meta-cognition and worry: A cognitive model of generalized anxiety disorder. Behavioural and Cognitive Psychotherapy, 23(3), 301–320. https://doi.org/10.1017/S1352465800015897